Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.
about
Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Differential clinical and prog ...... sine kinase inhibitor therapy.
@en
Differential clinical and prog ...... sine kinase inhibitor therapy.
@nl
type
label
Differential clinical and prog ...... sine kinase inhibitor therapy.
@en
Differential clinical and prog ...... sine kinase inhibitor therapy.
@nl
prefLabel
Differential clinical and prog ...... sine kinase inhibitor therapy.
@en
Differential clinical and prog ...... sine kinase inhibitor therapy.
@nl
P2093
P2860
P356
P1433
P1476
Differential clinical and prog ...... sine kinase inhibitor therapy.
@en
P2093
H M Kantarjian
L J Medeiros
R N Miranda
P2860
P2888
P356
10.1038/BCJ.2016.27
P577
2016-05-06T00:00:00Z
P6179
1003183985